Respiratory Immunopharmacology
1 – 10 of 92
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma
(
- Contribution to journal › Article
-
Mark
Physicochemical metamorphosis of re-aerosolized urban PM2.5
(
- Contribution to journal › Article
-
Mark
ERS International Congress 2023 : highlights from the Airway Diseases Assembly
(
- Contribution to journal › Article
-
Mark
Airway hyperresponsiveness correlates with airway TSLP in asthma independent of eosinophilic inflammation
2024) In Journal of Allergy and Clinical Immunology(
- Contribution to journal › Article
- 2023
-
Mark
Ers international congress 2022 : Highlights from the airway diseases assembly
(
- Contribution to journal › Article
-
Mark
New aspects of allergic mechanisms and innate immunity in asthma. Alarmins as upstream mediators of asthma inflammation.
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Airway hyperresponsiveness reflects corticosteroid-sensitive mast cell involvement across asthma phenotypes
(
- Contribution to journal › Article
-
Mark
Mast Cell Tryptase Promotes Airway Remodeling by Inducing Anti-Apoptotic and Cell Growth Properties in Human Alveolar and Bronchial Epithelial Cells
(
- Contribution to journal › Article
-
Mark
Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study) : A Double-Blind Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
C57Bl/6N mice have an attenuated lung inflammatory response to dsRNA compared to C57Bl/6J and BALB/c mice
(
- Contribution to journal › Article